US Urological Science

Current Concepts In The Treatment Of Penile Cancer

Penile cancer is uncommon in Australia, yet its effects can be profound when diagnosis is delayed or treatment threatens sexual function, urination, body image and intimate relationships. Most cases are squamous cell carcinomas arising from the glans, foreskin or penile skin. A persistent ulcer, lump, colour change, bleeding area, discharge or unpleasant odour deserves medical assessment, particularly when it does not settle with simple treatment.

Treatment has shifted towards accurate biopsy, careful staging and organ-preserving therapy whenever oncologically safe. Radical surgery remains appropriate for some advanced tumours, but many men can avoid unnecessary loss of penile tissue through local excision, laser treatment, glans-preserving surgery or selected radiotherapy. Management of the groin lymph nodes is equally important because microscopic spread can exist even when the groins feel normal.

The best decisions are made through a multidisciplinary team involving urologists, pathologists, radiologists, radiation oncologists, medical oncologists, specialist nurses and, where needed, sexual health or psychological clinicians. Evidence changes gradually because the disease is rare, so clinicians and patients benefit from reliable peer-reviewed sources such as Urological Science, alongside contemporary international and Australian guidance.

Recognising Disease Early

Penile squamous cell carcinoma often develops from a precursor lesion. Human papillomavirus, phimosis, chronic inflammation, smoking, poor genital hygiene and conditions such as lichen sclerosus can contribute to risk, although no single factor explains every case. HPV-associated disease may have different biological features from HPV-independent cancer, making pathological classification valuable.

A lesion should be examined rather than repeatedly treated as thrush, dermatitis or an infection without review. A GP can arrange referral to a urologist or a specialist sexual health service. Men may feel embarrassed, especially in smaller communities or regional areas, but clinicians are accustomed to assessing genital symptoms. Prompt assessment is particularly important when the foreskin is difficult to retract, the lesion is indurated, or there is persistent bleeding.

Confirming Diagnosis And Stage

Diagnosis requires a biopsy, usually taken from the most representative area while preserving as much normal tissue as possible. The pathology report should describe tumour type, grade, depth of invasion, lymphovascular or perineural invasion, and whether the margins are involved. These findings help estimate the chance of spread and guide the intensity of treatment.

Clinical examination of the groins is essential, but a normal examination cannot reliably exclude microscopic nodal disease. Ultrasound with needle sampling may help when a groin node is enlarged or suspicious. MRI can clarify local extension in selected cases, particularly when the tumour is large or the anatomy is difficult to assess. Broader urological guidance, such as paediatric reflux guidance, also illustrates why recommendations should be interpreted according to the patient’s age, anatomy and disease context rather than copied across conditions.

Preserving Function Through Local Treatment

For small, superficial cancers confined to the glans or prepuce, options may include wide local excision, circumcision, laser ablation in carefully selected lesions, glans resurfacing or partial glansectomy. The aim is clear cancer margins while retaining useful penile length, sensation and the ability to urinate standing where possible. Topical therapies may have a role for certain non-invasive precursor conditions, but they are not suitable substitutes for biopsy and definitive treatment of invasive cancer.

Organ preservation requires disciplined follow-up because local recurrence can occur. A conservative operation is successful only when the tumour is completely removed and the patient can attend regular reviews. For more extensive disease, partial penectomy may provide reliable cancer control with preservation of adequate length for urination. Total penectomy and perineal urethrostomy are reserved for tumours that cannot be safely treated with a lesser operation.

Perioperative planning should account for medications and general health. A man taking warfarin, apixaban, rivaroxaban or antiplatelet therapy needs an individualised plan rather than abruptly stopping treatment; practical principles are discussed in perioperative anticoagulation advice. Kidney function, diabetes, smoking, cardiovascular disease and frailty can also affect wound healing and anaesthetic risk.

Managing Groin Nodes

Inguinal lymph-node involvement is one of the strongest predictors of outcome. If nodes are clearly enlarged or biopsy-proven to contain cancer, treatment may involve therapeutic inguinal lymphadenectomy, sometimes with pelvic node surgery and chemotherapy depending on the number and location of involved nodes. The operation can be curative in selected men, but it carries risks including lymphoedema, wound breakdown, infection, numbness and prolonged recovery.

When the primary tumour has high-risk features but the groins appear clinically negative, dynamic sentinel lymph-node biopsy can identify hidden metastases while reducing the complications associated with a full dissection. It requires appropriate imaging, surgical expertise and a centre experienced in the technique. Surveillance may be reasonable for genuinely low-risk disease, but it must be structured and reliable rather than based on occasional self-checks.

Patients should be told how to recognise leg swelling, fluid collections, fever and wound problems after groin surgery. Compression garments, physiotherapy and lymphoedema services can be useful when swelling develops. Shared decision-making should weigh the estimated risk of occult spread against the long-term effects of nodal surgery.

Radiotherapy And Systemic Therapy

Radiotherapy may be considered for selected primary tumours, especially when preservation of the penis is a priority and the lesion is suitable for external-beam or brachytherapy approaches. It can also be used after surgery when margins remain concerning or nodal disease has features associated with a high risk of recurrence. Skin reactions, discomfort, narrowing of the urethral opening and late tissue changes should be discussed before treatment.

Chemotherapy is used in selected locally advanced or metastatic settings, sometimes before surgery to shrink disease and sometimes alongside radiotherapy. Regimens depend on kidney function, performance status, previous therapy and local expertise. For recurrent or metastatic cancer, platinum-based chemotherapy may be considered, while immunotherapy or targeted approaches may be available for selected molecular or clinical circumstances. Access and eligibility can change as evidence develops.

Because penile cancer is rare, clinical trials are especially valuable. Claims found on social media should be checked against peer-reviewed research, recognised cancer centres and government or professional guidance. Even a polished online page, such as an explanation of Lightning Wilds slots, has no authority for cancer decisions; patients need sources that identify authors, evidence and conflicts of interest.

Care In Australian Practice

Australia’s geography shapes cancer care. A man living in regional Queensland, Western Australia or the Northern Territory may need to travel to Brisbane, Perth, Darwin, Adelaide, Melbourne or Sydney for sentinel-node surgery, radiotherapy or a rare-cancer multidisciplinary review. Telehealth can support follow-up and treatment discussions, but it cannot replace examination when a new lesion or groin swelling appears.

The public system provides access to specialist treatment through Medicare, although referral pathways and waiting times vary between states, hospitals and metropolitan services. Private insurance may offer different scheduling options, but out-of-pocket costs for consultations, pathology, imaging and allied health care should be explained clearly. A GP referral, copies of biopsy results and a medication list can make the first specialist appointment more efficient.

Culturally safe care matters, including for Aboriginal and Torres Strait Islander men who may face transport barriers, distrust arising from past experiences, or difficulty taking time away from work and family responsibilities. Aboriginal health services, patient navigators and interpreters can help coordinate appointments. Plain language—“a suspicious spot”, “the groin glands”, and “keeping as much tissue as is safe”—may make complex choices easier to discuss.

Treatment should include sexual and psychological wellbeing from the start. Changes in erections, ejaculation, genital appearance and fertility can affect relationships and confidence. Partners may need information too, while men should be reassured that seeking counselling or sexual medicine support is a normal part of cancer care, not an indication that treatment has failed.

Practical Priorities For Patients And Clinicians

A sound treatment pathway combines early recognition, expert pathology, risk-based nodal management and realistic discussion of function. The following priorities help keep care focused:

A written plan should state who will coordinate care, when the next examination will occur, which warning symptoms require urgent contact and how results will be communicated. Regular surveillance is particularly important during the first years after treatment, when local or nodal recurrence is more likely, while lifelong awareness remains sensible.

Men should contact a GP or urology service promptly about a persistent penile change rather than waiting for it to disappear. Clinicians can use current evidence, multidisciplinary review and patient-centred discussion to select treatment that protects both cancer outcomes and quality of life.